Westmount Capital is pleased to bring for the second time to Milano VentriPoint Diagnostics Ltd.., a Canadian Medical Device company that is focused on the development and commercialization of cardiac diagnostic tools.
The presentation made by Dr. George Adams and Dr. Alvira Makanovic took place at the Hotel Sheraton Diana Majestic of Milan, Italy on Friday, October 21st, 2022
About Ventripoint Diagnostics (VPT-V).
The VMS+ is a diagnostic aid that was developed to provide a point of care solution to better communicate the heart’s structure and function without the need for MRI.
The VMS+ marries the ingenuity of the cardiac MRI and Echo with the power of Ventripoint’s KBR technology. KBR enables you to construct a 3D model of the heart and calculates volumes and ejection fractions for all chambers with an accuracy comparable to the MRI.
Share Structure (as of October 7th, 2022: C$0.27)
Shares outstanding: 156,513,905; Market Cap: C$42,3 million.
For further information, please visit VentriPoint Diagnostics website:
https://www.ventripoint.com
And stock chart:
https://money.tmx.com/en/quote/VPT
Dr. George Adams – Chairman of the Board; Member of Nominating & Corporate Governance Committee and Audit Committee is a scientist, a serial entrepreneur and a financier.
His previous position was CEO of Amorfix Life Sciences (TSX:AMF) from 2005-2010. He was Chairman of Sernova Corp (TSXV:SVA) and President and CEO of the UT Innovations Foundation from 1999 until 2004.
Prior to this, he held research and executive positions with Boston Scientific Inc, Pfizer Inc, Corvita Canada Inc., University of Ottawa and Canadian Red Cross, Blood Transfusion Service.
He has been instrumental in founding over 30 companies who have raised $100 million and has been a Director of 10 venture capital funds and 10 start-up companies.
Dr. Adams was awarded a World Economic Foundation Technology Pioneer for 2007 and TBI Company of the year in 2009. Dr Adams has 124 scientific publications and is a reviewer for major scientific journals, federal granting agencies and Centres of Excellence.
care of the redaction
